DUBLIN–(BUSINESS WIRE)–The “Global Markets for Vaccine Technologies” report has been added to ResearchAndMarkets.com’s offering.

The report explains critical trends in the vaccine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to stakeholders and potential entrants.

There has been increasing government interest in various parts of the world due to sudden outbreaks of major diseases such as Ebola, Zika virus, chikungunya, avian influenza, the H1N1 virus, and COVID-19; these outbreaks have been the primary reason for the recent market growth.

Broadly speaking, depending on whether they prevent diseases or treat pre-existing ones, vaccines can be divided into prophylactic and therapeutic vaccines. In contrast, animal vaccines are categorized by food-producing animals (porcine, bovine, poultry, ovine, fish) and companion animals (canine, feline and equine vaccines), as well as vaccines for other animal species.

This study looks at most of the systems affected by factors such as considerable research and development (R&D) spending and increasing competition and new technologies, which are giving direction to the market. These advancements, new product launches, and changing lifestyles are influencing the future market growth.

Company merger acquisition strategies and collaborations are also covered in this report. Additionally, this study discusses the strengths and weaknesses of each strategy type considering new technologies, growing competition, and changing customer needs.

The market has also been analyzed based on the application of current vaccines. Categories considered in this report include meningococcal/pneumococcal vaccines, influenza vaccines, pediatric polio/pertussis/Hib vaccines, adult/adolescent booster vaccines, vaccines for travel-related and other endemic diseases, HPV vaccines, rotavirus vaccines, and other (minor) vaccines.

This study details market growth among vaccine manufacturers and end-users. Genomic research centers, academic institutions, government and private laboratories, and various hospital settings, as well as pharmaceutical, diagnostic, and biotechnology companies and physicians, will find this study to be of interest.

The Report Includes:

• 34 data tables and 54 additional tables
• A descriptive overview of the global markets for vaccine technologies and their applications
• Analyses of the global market trends, with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
• Evaluation of the current market size, market estimation and forecast, pipeline analysis of new products; and discussion of opportunities, drivers and challenges affecting the overall marketplace
• The brief general outlook of the recent market developments, technological advancements, government regulations and policies, patent analyses and upcoming technologies, R&D activities related to the vaccine technology industry
• Identification of present and future strategies within the vaccine technology market and examination of vaccines for both humans and animals
• Opportunities and highlights of this innovation-driven vaccine technologies market, and the major regions and countries involved in market developments and their immunization schedule
• A separate chapter on COVID-19 pandemic impact on the present and future vaccines market, major COVID-19 vaccine candidates under development, and impact of the outbreak on vaccine supplies
• Detailed company profiles of the market-leading participants, including Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bayer Animal Health, GlaxoSmithKline (GSK), Merck & Co. Inc., Johnson & Johnson Inc., Novartis, Pfizer, Sanofi Pasteur, and Thermo Fisher Scientific

Company Profiles

• Abbott Laboratories
• Astellas Pharma Inc.
• Astrazeneca Plc
• Baxter International Inc.
• Bayer Animal Health
• Bharat Biotech International Ltd.
• Biological E. Ltd.
• Bio-Manguinhos
• Bioproperties Pty Ltd.
• Boehringer Ingelheim Gmbh
• Bul Bio National Center Of Infectious And Parasitic Diseases Ltd. (Bb-Ncipd Ltd.)
• Cadila Healthcare Ltd. (Zydus Cadila)
• Ceva Sante Animale
• China National Biotec Group (Cnbg)
• Colorado Serum Co.
• CSL Ltd.
• Elanco Animal Health
• Emergent Biosolutions Inc.
• Fatro Spavia
• GE Healthcare
• Geneone Life Sciences Inc.
• Precigen Inc. (Formerly Intrexon)
• Geovax
• Glaxosmithkline Plc
• Green Cross Corp.
• Ibio Inc.
• Institut Pasteur De Dakar
• Johnson & Johnson Inc.
• LG Life Sciences
• Maxcyte Inc.
• Merck & Co., Inc.
• Novartis Pharma Ag
• Panacea Biotec Ltd.
• Pfenex Inc.
• Pfizer Inc.
• Profectus Biosciences Inc.
• PT Bio Farma
• Replikins Ltd.
• Sanofi Pasteur
• Serum Institute Of India Ltd.
• Statens Serum Institut
• Thermo Fisher Scientific
• Valneva Se
• Virbac
• Zoetis Inc.

For more information about this report visit https://www.researchandmarkets.com/r/xbca31